Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Torresi

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
The Journal of General Virology|May 6, 2016
Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell lineL Earnest-Silveira, B Chua, R Chin, et al.
International Journal of Molecular Sciences|January 21, 2022
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 InfectionBang M Tran, Samantha L Grimley, Julie L McAuley, et al.
Cell Death & Disease|June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P Clark, Thao Huynh, Shringar Rao, et al.
Analytical Chemistry|August 6, 2025
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like ParticlesAnkit Dodla, Magdalena Giergiel, Aaron Mclean, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infectionJohn J Miles, Duangtawan Thammanichanond, Sarah Moneer, et al.
Annals of Internal Medicine|April 5, 2013
GeoSentinel surveillance of illness in returned travelers, 2007-2011Karin Leder, Joseph Torresi, Michael D Libman, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Frontiers in Microbiology|June 23, 2023
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidatesSimon Collett, Linda Earnest, Julio Carrera Montoya, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
The Journal of General Virology|May 6, 2016
Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell lineL Earnest-Silveira, B Chua, R Chin, et al.
International Journal of Molecular Sciences|January 21, 2022
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 InfectionBang M Tran, Samantha L Grimley, Julie L McAuley, et al.
Cell Death & Disease|June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P Clark, Thao Huynh, Shringar Rao, et al.
Analytical Chemistry|August 6, 2025
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like ParticlesAnkit Dodla, Magdalena Giergiel, Aaron Mclean, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infectionJohn J Miles, Duangtawan Thammanichanond, Sarah Moneer, et al.
Annals of Internal Medicine|April 5, 2013
GeoSentinel surveillance of illness in returned travelers, 2007-2011Karin Leder, Joseph Torresi, Michael D Libman, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Frontiers in Microbiology|June 23, 2023
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidatesSimon Collett, Linda Earnest, Julio Carrera Montoya, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.
Pageof 13